LSN News › World News

World · World News Bureau

Kratom and synthetic alternatives pose addiction risks despite growing popularity

Plant-based substances marketed as natural remedies are gaining widespread use across Asia and beyond, but medical experts warn they carry significant dependency potential similar to opioids. Users report miraculous pain relief and mood enhancement, yet risk developing serious addictions with limited treatment options.

LSN World News · 13 November 2026

Kratom, a tropical plant native to Southeast Asia, and its synthetic derivative 7-hydroxymitragynine have emerged as increasingly popular alternatives to conventional pharmaceuticals, particularly among those seeking relief from chronic pain and opioid withdrawal symptoms. Proponents describe the substances as life-changing, with many users crediting them for dramatic improvements in their quality of life and ability to function daily. However, medical professionals are raising alarm bells about the addiction potential of these substances, which work on similar neural pathways to opioids despite their botanical origins.

The active compounds in kratom interact with opioid receptors in the brain, creating a mechanism for physical dependence that mirrors traditional opioid addiction. Users who consume kratom regularly can develop tolerance, requiring escalating doses to achieve the same effects. Withdrawal symptoms upon cessation include muscle aches, anxiety, insomnia, and mood disturbances, complicating efforts to discontinue use. The ease of access and perception of kratom as a natural, safer alternative have contributed to its proliferation in unregulated markets across South and Southeast Asia as well as Western countries.

The lack of regulatory oversight has created a parallel market where product quality, potency, and purity remain inconsistent and largely unmonitored. Medical infrastructure in many regions remains unprepared to address kratom-related addiction, with few treatment protocols or rehabilitation resources available to those struggling with dependence. Public health officials face mounting pressure to implement evidence-based policies that acknowledge both the therapeutic potential and abuse liability of these substances.